# Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

> **NCT00329966** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 100 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Surface Antigen, Inactivated, Influenza (form.2006-07)

## Key facts

- **NCT ID:** NCT00329966
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (—)
- **Last updated:** 2006-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329966, "Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00329966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*